Morphic (MORF) Downgraded by Zacks Investment Research to Sell

Morphic} stock has undergone multiple analysts rating changes in the recent past.  Morphic Downgraded by Zacks Investment Research on 10/15/2021. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More Morphic (MORF) Downgraded by Zacks Investment Research to Sell